Combatting substandard and falsified medicines: a view from Rwanda

PLoS Med. 2013;10(7):e1001476. doi: 10.1371/journal.pmed.1001476. Epub 2013 Jul 2.

Abstract

Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.

Please see later in the article for the Editors' Summary

MeSH terms

  • Commerce / legislation & jurisprudence*
  • Commerce / standards
  • Counterfeit Drugs / analysis*
  • Counterfeit Drugs / supply & distribution
  • Drug Contamination
  • Drug Industry / legislation & jurisprudence*
  • Drug Industry / standards
  • Government Regulation
  • International Cooperation / legislation & jurisprudence*
  • Malaria / drug therapy
  • Pharmacovigilance
  • Quality Control
  • Rwanda
  • Tuberculosis / drug therapy
  • World Health Organization

Substances

  • Counterfeit Drugs

Grants and funding

No specific funding was received for writing this article.